loadpatents
name:-0.027467966079712
name:-0.015088081359863
name:-0.0045309066772461
KUMON; Hiromi Patent Filings

KUMON; Hiromi

Patent Applications and Registrations

Patent applications and USPTO patent grants for KUMON; Hiromi.The latest application filed is for "method for treatment of hepatic cancer using reic/dkk-3 gene in combination with anti-tumor agent".

Company Profile
4.24.27
  • KUMON; Hiromi - Okayama JP
  • KUMON; Hiromi - Okayama-shi Okayama
  • KUMON; Hiromi - Okayami-shi JP
  • - Okayama JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
METHOD FOR TREATMENT OF HEPATIC CANCER USING REIC/Dkk-3 GENE IN COMBINATION WITH ANTI-TUMOR AGENT
App 20220280601 - KUMON; Hiromi ;   et al.
2022-09-08
A COMBINATION THERAPY FOR TREATMENT OF THORACIC CANCER USING Ad-REIC/Dkk-3 AND A CHECKPOINT INHIBITOR
App 20210402010 - KUMON; Hiromi ;   et al.
2021-12-30
Antibody that specifically recognizes and binds to REIC/Dkk-3 protein having active structure and monitoring of cancer treatment using such anti-REIC/Dkk-3 antibody
Grant 10,782,296 - Kumon , et al. Sept
2020-09-22
TGF INHIBITOR CONTAINING REIC/Dkk-3 PROTEIN AS ACTIVE INGREDIENT
App 20190330291 - KINOSHITA; Rie ;   et al.
2019-10-31
A COMBINATION THERAPY USING REIC/Dkk-3 GENE AND A CHECKPOINT INHIBITOR
App 20190015506 - KUMON; Hiromi ;   et al.
2019-01-17
Antibody That Specifically Recognizes And Binds To Reic/dkk-3 Protein Having Active Structure And Monitoring Of Cancer Treatment Using Such Anti-reic/dkk-3 Antibody
App 20180267040 - Kumon; Hiromi ;   et al.
2018-09-20
Gene Expression Cassette And Product Thereof
App 20180265894 - Sakaguchi; Masakiyo ;   et al.
2018-09-20
Conditionally replicating adenovirus to express REIC gene
Grant 10,071,126 - Kumon , et al. September 11, 2
2018-09-11
Conditionally Replicating Adenovirus To Express Reic Gene
App 20170202892 - KUMON; Hiromi ;   et al.
2017-07-20
Partial region polypeptide of REIC/Dkk-3 protein
Grant 9,644,013 - Kumon , et al. May 9, 2
2017-05-09
System for increasing gene expression and vector comprising the system
Grant 9,493,776 - Kumon , et al. November 15, 2
2016-11-15
Direct administration of REIC/Dkk-3 to mesothelioma
Grant 9,475,865 - Kumon , et al. October 25, 2
2016-10-25
Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same
Grant 9,458,513 - Ishikawa , et al. October 4, 2
2016-10-04
Partial Region Polypeptide of REIC/Dkk-3 Protein
App 20160176938 - Kumon; Hiromi ;   et al.
2016-06-23
Decreasing cancer cell proliferation with WNT remaining active
Grant 9,243,048 - Namba , et al. January 26, 2
2016-01-26
REIC-expressing adenovirus vector
Grant 9,222,107 - Kumon , et al. December 29, 2
2015-12-29
Pharmaceutical Composition For Cancer Treatment Including Fusion Protein
App 20150284444 - Watanabe; Masami ;   et al.
2015-10-08
Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancer
Grant 8,946,173 - Kumon , et al. February 3, 2
2015-02-03
Reic-expressing Adenovirus Vector
App 20140147917 - Kumon; Hiromi ;   et al.
2014-05-29
Pharmaceutical Composition For Treating Or Preventing Cancer By Inducing Dendritic Cell-like Differentiation From Monocytes To Improve Anticancer Immune Activity
App 20140056945 - KUMON; Hiromi ;   et al.
2014-02-27
Apoptosis-inducing agent for prostate cancer cells
Grant 8,658,611 - Kumon , et al. February 25, 2
2014-02-25
Therapeutic agent for malignant mesothelioma and immunostimulant
Grant 8,658,612 - Kumon , et al. February 25, 2
2014-02-25
Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same
Grant 8,618,273 - Kumon , et al. December 31, 2
2013-12-31
Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same
Grant 08618273 -
2013-12-31
Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity
Grant 8,614,093 - Kumon , et al. December 24, 2
2013-12-24
Partial Fragment of REIC/Dkk-3 Gene and Cancer Therapeutic Agent Comprising the Same
App 20130274199 - KUMON; HIROMI ;   et al.
2013-10-17
Partial Region Polypeptide of REIC/Dkk-3 Protein
App 20130267025 - Kumon; Hiromi ;   et al.
2013-10-10
Antibody against calcified globule and use of the same
Grant 8,410,251 - Matsuura , et al. April 2, 2
2013-04-02
Primer And Probe For Detecting Chlamydia Trachomatis, And Method For Detecting Chlamydia Trachomatis Using Same
App 20130059306 - Ishikawa; Tomokazu ;   et al.
2013-03-07
System For Increasing Gene Expression And Vector Comprising The System
App 20120309050 - Kumon; Hiromi ;   et al.
2012-12-06
Pharmaceutical Composition For Treating Or Preventing Cancer By Inducing Dendritic Cell-like Differentiation From Monocytes To Improve Anticancer Immune Activity
App 20120034251 - Kumon; Hiromi ;   et al.
2012-02-09
Cancer Cell Death Inducing Agent Having Effects Of Potentiating Anticancer Drug Against Anticancer-drug-resistant Cancer
App 20110269824 - Kumon; Hiromi ;   et al.
2011-11-03
Therapeutic Agent for Malignant Mesothelioma and Immunostimulant
App 20110189237 - Kumon; Hiromi ;   et al.
2011-08-04
Antibody Against Calcified Globule And Use Of The Same
App 20110182817 - Matsuura; Eiji ;   et al.
2011-07-28
Apoptosis-inducing Agent For Prostate Cancer Cells
App 20110166545 - KUMON; Hiromi ;   et al.
2011-07-07
Primer And Probe For Detecting Chlamydophila Caviae, As Well As A Chlamydophila Caviae Detection Method Using The Same
App 20100323365 - Ishikawa; Tomokazu ;   et al.
2010-12-23
Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same
App 20100173404 - Kumon; Hiromi ;   et al.
2010-07-08
Apoptosis-Inducing Agent for Prostate Cancer Cells
App 20090005538 - Kumon; Hiromi ;   et al.
2009-01-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed